Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01820650
Other study ID # 12-001
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date February 2013
Est. completion date October 2023

Study information

Verified date October 2023
Source Restor3D
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.


Description:

If the patient has previously received a standard total knee replacement in their contralateral knee, the primary endpoint questionnaire and some secondary endpoint questionnaires will be completed regarding BOTH their iTotal® CR knee and their standard total knee for all time points where questionnaires are required by the protocol.


Recruitment information / eligibility

Status Terminated
Enrollment 359
Est. completion date October 2023
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinical condition included in the approved Indications For Use for the iTotal® CR - Osteoarthritis, as confirmed by the investigator's assessment of disease status at screening visit that warrants a TKR procedure. Disease status is assessed by Clinical and Radiographic assessment. - Willingness to participate in the clinical study, to give informed consent and to attend all follow-up visits - > 18 years of age Exclusion Criteria: - Simultaneous bilateral procedure required - BMI > 40 - Active malignancy (defined as a history of any invasive malignancy - except non-melanoma skin cancer), unless patient has been treated with curative intent and there have been no clinical signs or symptoms of the malignancy for at least 5 years - Poorly Controlled diabetes - Neuromuscular conditions which prevent patient from participating in study activities - Active local or systemic infection - Immunocompromised - Fibromyalgia or other general body pain related condition - Rheumatoid arthritis or other forms of inflammatory joint disease - Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in the area of the joint to be operated to an extent that the procedure is unjustified - Diagnosed with or receiving treatment for Osteoporosis - Other physical disability affecting the hips, spine, or contralateral knee. - Severe instability due to advanced loss of osteochondral structure - Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO) - Compromised PCL or collateral ligament - Severe fixed valgus or varus deformity of >15º - Extensor lag > 15 º - Fixed flexion contracture = 15 º - Unwilling or unable to comply with study requirements - Participation in another clinical study which would confound results - Allergy to any of the implant materials

Study Design


Intervention

Device:
iTotal G2 CR Knee Replacement System
Total Knee replacement

Locations

Country Name City State
United States JFK Medical Center Atlantis Florida
United States EMMC - Orthopaedic Surgery of Maine Bangor Maine
United States Great Lakes Bone and Joint Battle Creek Michigan
United States Advanced Orthopedics and Sports Medicine Cypress Texas
United States Orthopaedic Instatute of Henderson Henderson Nevada
United States Joint Replacement Associates Houston Texas
United States Desert Orthopedic Center Las Vegas Nevada
United States Mansfield Orthopaedics Morrisville Vermont
United States Tennessee Orthopaedic Alliance Nashville Tennessee

Sponsors (1)

Lead Sponsor Collaborator
Restor3D

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary 2011 Knee Society Score 1 Year
See also
  Status Clinical Trial Phase
Completed NCT03277066 - A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis Phase 2
Recruiting NCT03090698 - Outcomes of Injections in Patients Waiting for Total Knee Replacement Phase 4
Completed NCT02556710 - A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee Phase 3
Withdrawn NCT02237846 - Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis Phase 1/Phase 2
Completed NCT02242435 - A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis Phase 3
Completed NCT02096393 - Patient Specific Instrumentation in TKR N/A
Completed NCT01849445 - Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study N/A
Completed NCT01704157 - A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device N/A
Active, not recruiting NCT01374230 - Long-Term Multicenter Evaluation of the E1® Tibial Bearing N/A
Not yet recruiting NCT01270412 - Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis Phase 2/Phase 3
Completed NCT01410409 - Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement N/A
Completed NCT02156440 - Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee Phase 2
Completed NCT01207115 - A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee Phase 2
Completed NCT01331278 - A Comparative Study of Knee Systems Phase 4
Completed NCT00988091 - Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee Phase 3
Completed NCT00970008 - Exploring Massage Benefits for Arthritis of the Knee Phase 2
Completed NCT00792727 - HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain Phase 3
Completed NCT00531427 - Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee Phase 3
Completed NCT00449696 - Gel-200 Versus Placebo in Osteoarthritis of the Knee Phase 3
Completed NCT04145011 - Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain N/A